 |
High-Dose Brachytherapy Effective for Soft Tissue Sarcoma in Children
High-dose brachytherapy (HBRT), alone or in combination with external beam radiation therapy (EBRT), produces "excellent" local control rates in pediatric soft tissue sarcoma, according to a report in the April 19th issue of the BMC journal Radiation Oncology. more...
Reduced Cancer Risk Seen with Statin Use
High-dose lipophilic statin use is associated with a significant reduction in the incidence of cancer, according to results of a study published in the April issue of the American Journal of Medicine. more...
Anti-Breast Cancer Benefit of Physical Activity Varies
The results of a literature review confirm that while all women are likely to reduce their risk of breast cancer with regular physical activity, certain subgroups benefit more than others. more...
FDA Defends Safety of Chemical Used in Baby Bottles
The U.S. Food and Drug Administration said on Wednesday said it sees no reason to tell consumers to stop using products such as baby bottles made with a controversial chemical found in many plastic items. more...
Nerve Block Useful for Hot Flushes and Sleep Trouble in Breast Cancer Survivors
A stellate-ganglion block can safely reduce hot flushes and improve nighttime sleep in survivors of breast cancer, according to results of a small pilot study reported in the May 15th online issue of The Lancet Oncology. more...
Family History of Breast Cancer Confers Lifetime Elevated Risk
Women who have a sister diagnosed with breast cancer remain at increased risk of breast cancer throughout their lives, epidemiologists in Sweden report in the Journal of the National Cancer Institute for May 21. more...
Physical Activity May Cut Risk of Premenopausal Breast Cancer
Premenopausal women who spend much of their leisure time in physical activities, especially in adolescence and early adulthood, are less likely to develop breast cancer than their more sedentary counterparts, according to a report in the Journal of the National Cancer Institute for May 21. more...
Cancer Drug Sales Predicted to Skyrocket
Sales of cancer drugs will grow at nearly double the rate of the global pharmaceutical market and could reach $80 billion by 2012, according to IMS Health, which tracks prescription drug sales. more...
|
|
|
|
 |